An HIV cure may work differently for women and men
Supporting PrEP in eastern Europe and central Asia
HIV PrEP also prevents hepatitis B – and works better than the hepatitis B vaccine
Evaluating point-of-care early infant diagnosis in Zambia and Zimbabwe
HIV cure at CROI: new data on antibodies, vaccines and genetically engineered T-cells
Older age and baseline kidney function are the key risk factors for renal dysfunction while taking HIV PrEP
Adherence clubs linked to 30% reduction in high viral load among postpartum South African women living with HIV
Weight gain after starting HIV treatment may have genetic influences
HIV-positive people with fatty liver disease are at high risk for fibrosis
